254 related articles for article (PubMed ID: 21148526)
1. Oral treatment for Mycobacterium ulcerans infection: results from a pilot study in Benin.
Chauty A; Ardant MF; Marsollier L; Pluschke G; Landier J; Adeye A; Goundoté A; Cottin J; Ladikpo T; Ruf T; Ji B
Clin Infect Dis; 2011 Jan; 52(1):94-6. PubMed ID: 21148526
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial.
Nienhuis WA; Stienstra Y; Thompson WA; Awuah PC; Abass KM; Tuah W; Awua-Boateng NY; Ampadu EO; Siegmund V; Schouten JP; Adjei O; Bretzel G; van der Werf TS
Lancet; 2010 Feb; 375(9715):664-72. PubMed ID: 20137805
[TBL] [Abstract][Full Text] [Related]
3. Painful Buruli ulcer in a Malian visitor to France.
Ezzedine K; Pistone T; Guir V; Malvy D
Acta Derm Venereol; 2010 Jul; 90(4):424. PubMed ID: 20574617
[No Abstract] [Full Text] [Related]
4. Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial.
Phillips RO; Robert J; Abass KM; Thompson W; Sarfo FS; Wilson T; Sarpong G; Gateau T; Chauty A; Omollo R; Ochieng Otieno M; Egondi TW; Ampadu EO; Agossadou D; Marion E; Ganlonon L; Wansbrough-Jones M; Grosset J; Macdonald JM; Treadwell T; Saunderson P; Paintsil A; Lehman L; Frimpong M; Sarpong NF; Saizonou R; Tiendrebeogo A; Ohene SA; Stienstra Y; Asiedu KB; van der Werf TS;
Lancet; 2020 Apr; 395(10232):1259-1267. PubMed ID: 32171422
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterium ulcerans disease: experience with primary oral medical therapy in an Australian cohort.
Friedman ND; Athan E; Hughes AJ; Khajehnoori M; McDonald A; Callan P; Rahdon R; O'Brien DP
PLoS Negl Trop Dis; 2013; 7(7):e2315. PubMed ID: 23875050
[TBL] [Abstract][Full Text] [Related]
6. [Paradoxical reactions and responses during antibiotic treatment for Mycobacterium ulcerans infection (Buruli ulcer). Four cases from French Guiana].
Sambourg E; Dufour J; Edouard S; Morris A; Mosnier E; Reynaud Y; Sainte-Marie D; Nacher M; Guégan JF; Couppié P
Ann Dermatol Venereol; 2014; 141(6-7):413-8. PubMed ID: 24951139
[TBL] [Abstract][Full Text] [Related]
7. Promising clinical efficacy of streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease).
Chauty A; Ardant MF; Adeye A; Euverte H; Guédénon A; Johnson C; Aubry J; Nuermberger E; Grosset J
Antimicrob Agents Chemother; 2007 Nov; 51(11):4029-35. PubMed ID: 17526760
[TBL] [Abstract][Full Text] [Related]
8. [Streptomycin injections for the treatment of Mycobacterium ulcerans (Buruli ulcer) in a rural health zone in the Democratic Republic of the Congo].
Kibadi K
Sante; 2007; 17(3):173-6. PubMed ID: 18180219
[TBL] [Abstract][Full Text] [Related]
9. Phagocytosis of Mycobacterium ulcerans in the course of rifampicin and streptomycin chemotherapy in Buruli ulcer lesions.
Schütte D; Umboock A; Pluschke G
Br J Dermatol; 2009 Feb; 160(2):273-83. PubMed ID: 19016694
[TBL] [Abstract][Full Text] [Related]
10. Management of Mycobacterium ulcerans infection in a pregnant woman in Benin using rifampicin and clarithromycin.
Dossou AD; Sopoh GE; Johnson CR; Barogui YT; Affolabi D; Anagonou SY; Zohoun T; Portaels F; Asiedu K
Med J Aust; 2008 Nov; 189(9):532-3. PubMed ID: 18976206
[No Abstract] [Full Text] [Related]
11. Paradoxical responses after start of antimicrobial treatment in Mycobacterium ulcerans infection.
Nienhuis WA; Stienstra Y; Abass KM; Tuah W; Thompson WA; Awuah PC; Awuah-Boateng NY; Adjei O; Bretzel G; Schouten JP; van der Werf TS
Clin Infect Dis; 2012 Feb; 54(4):519-26. PubMed ID: 22156855
[TBL] [Abstract][Full Text] [Related]
12. [Bifocal Buruli ulcer: multiple cephalic lesions after initiation of medical treatment].
Vagamon B; Ahogo KC; Aka BR; Diabaté A; Kouassi YI; Kourouma SH; Traoré C; Gue I; Yoboue P; Kanga JM; Taieb A
Ann Dermatol Venereol; 2013 Feb; 140(2):125-8. PubMed ID: 23395495
[TBL] [Abstract][Full Text] [Related]
13. Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort study.
O'Brien DP; McDonald A; Callan P; Robson M; Friedman ND; Hughes A; Holten I; Walton A; Athan E
PLoS Negl Trop Dis; 2012 Jan; 6(1):e1473. PubMed ID: 22272368
[TBL] [Abstract][Full Text] [Related]
14. Exploration of a standard treatment for Buruli ulcer through a comprehensive analysis of all cases diagnosed in Japan.
Sugawara M; Ishii N; Nakanaga K; Suzuki K; Umebayashi Y; Makigami K; Aihara M
J Dermatol; 2015 Jun; 42(6):588-95. PubMed ID: 25809502
[TBL] [Abstract][Full Text] [Related]
15. Duodenal ulcer healing after 7-day treatment: a pilot study with lansoprazole, amoxicillin and clarithromycin.
Schütze K; Hentschel E
Z Gastroenterol; 1995 Nov; 33(11):651-3. PubMed ID: 8600661
[TBL] [Abstract][Full Text] [Related]
16. Increasing Experience with Primary Oral Medical Therapy for Mycobacterium ulcerans Disease in an Australian Cohort.
Friedman ND; Athan E; Walton AL; O'Brien DP
Antimicrob Agents Chemother; 2016 May; 60(5):2692-5. PubMed ID: 26883709
[TBL] [Abstract][Full Text] [Related]
17. Outcome of Streptomycin-Rifampicin treatment of Buruli Ulcer in two Ghanaian districts.
Iddrisah FN; Yeboah-Manu D; Nortey PA; Nyarko KM; Anim J; Antara SN; Kenu E; Wurapa F; Afari EA
Pan Afr Med J; 2016; 25(Suppl 1):13. PubMed ID: 28149438
[TBL] [Abstract][Full Text] [Related]
18. Environmental and health-related risk factors for Mycobacterium ulcerans disease (Buruli ulcer) in Benin.
Nackers F; Johnson RC; Glynn JR; Zinsou C; Tonglet R; Portaels F
Am J Trop Med Hyg; 2007 Nov; 77(5):834-6. PubMed ID: 17984337
[TBL] [Abstract][Full Text] [Related]
19. Providing insight into the incubation period of Mycobacterium ulcerans disease: two case reports.
Amoako YA; Frimpong M; Awuah DO; Plange-Rhule G; Boakye-Yiadom E; Agbavor B; Sarpong F; Ahor H; Adu E; Danso KG; Abass MK; Asiedu K; Wansbrough-Jones M; Phillips RO
J Med Case Rep; 2019 Jul; 13(1):218. PubMed ID: 31315637
[TBL] [Abstract][Full Text] [Related]
20. Buruli ulcer. A disabling infection.
Prescrire Int; 2010 Nov; 19(110):261-2. PubMed ID: 21284361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
